Direxion Daily Pharmaceutical and Medical Bull 3X Shares ETF (PILL) |
| 12.42 0.43 (3.59%) 01-14 12:00 |
| Open: | 11.91 |
| High: | 12.4599 |
| Low: | 11.895 |
| Volume: | 33,315 |
| Market Cap: | 18(M) |
| PE Ratio: | 34.64 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 15.57 |
| Resistance 1: | 13.33 |
| Pivot price: | 12.35 |
| Support 1: | 11.91 |
| Support 2: | 11.03 |
| 52w High: | 13.33 |
| 52w Low: | 3.62 |
The fund invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or to ETFs that track the index. The index is a modified equal-weighted index that is designed to measure performance of the stocks comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry. The fund is non-diversified.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Tue, 16 Dec 2025
Top Performing Leveraged/Inverse ETFs: 12/14/2025 - ETF Database
Wed, 19 Nov 2025
Top Performing Leveraged/Inverse ETFs: 11/16/2025 - ETF Database
Mon, 29 Sep 2025
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms - Benzinga
Fri, 19 Sep 2025
As M&A Deals Rise, Can Biotech Pharma Break Loose? - ETF Trends
Tue, 19 Aug 2025
Top Performing Leveraged/Inverse ETFs: 08/17/2025 - ETF Database
Tue, 12 Aug 2025
CURE: Make an Adventurous Bet on an Undervalued Sector - ETF Trends
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
